Idiopathic Pulmonary Fibrosis
Links shared publicly online about this topic
Idiopathic pulmonary fibrosis : The Lancet
thelancet.com — “Idiopathic pulmonary fibrosis. By - Prof Talmadge E King MD, Prof Annie Pardo PhD, Moisés Selman MD” View full resource at thelancet.com
Most Recently Shared on June 28, 2011 at 3:56 pm By:
Read a Seminar on idiopathic pulmonary fibrosis http://t.co/po3jdl7
Idiopathic pulmonary fibrosis : The Lancet
thelancet.com — “Idiopathic pulmonary fibrosis. By - Prof Talmadge E King MD, Prof Annie Pardo PhD, Moisés Selman MD” View full resource at thelancet.com
Most Recently Shared on June 28, 2011 at 3:57 pm By:
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial http://t.co/ZxItNgT
AJMS Presents Update on Idiopathic Pulmonary Fibrosis
newswise.com — “AJMS Presents Update on Idiopathic Pulmonary Fibrosis” View full resource at newswise.com
Most Recently Shared on July 7, 2011 at 1:50 pm By:
#health news: AJMS Presents Update on Idiopathic Pulmonary Fibrosis: Idiopathic pulmonary fibrosis (IPF) is a co... http://bit.ly/p4dhlf
Hope for patients with mild idiopathic pulmonary fibrosis
sciencedaily.com — “A new therapy shows promise for patients with mild idiopathic pulmonary fibrosis. According to researchers, inhaled N-acetylcysteine (NAC) monotherapy preserves more lung function in some idiopathic pulmonary fibrosis (IPF) patients than no therapy.” View full resource at sciencedaily.com
Most Recently Shared on May 18, 2010 at 2:45 pm By:
Hope for patients with mild idiopathic pulmonary fibrosis: A new therapy shows promise for patients with mild idio... http://bit.ly/cfKViD
Hope for Patients with Mild Idiopathic Pulmonary Fibrosis
newswise.com — “A new therapy shows promise for patients with mild idiopathic pulmonary fibrosis. According to researchers in Japan, inhaled N-acetylcysteine (NAC) monotherapy preserves more lung function in some idiopathic pulmonary fibrosis (IPF) patients than no therapy.” View full resource at newswise.com
Most Recently Shared on May 18, 2010 at 2:53 pm By:
newswise Health Communicator and Health News
Hope for Patients with Mild Idiopathic Pulmonary Fibrosis: A new therapy shows promise for patients with mild idio... http://bit.ly/biNrIt
Registration open for idiopathic pulmonary fibrosis healthcare summit
news-medical.net — “The Pulmonary Fibrosis Foundation (PFF) announced today that registration is now open for the IPF Summit 2011: From Bench to Bedside. The conference will feature an innovative two-day continuing medical education (CME) program for physicians, researchers, and other health care professionals. Additionally there will be a separate one-day patient, family member, and caregiver program to address the growing educational needs of the idiopathic pulmonary fibrosis (IPF) community.” View full resource at news-medical.net
Most Recently Shared on February 14, 2011 at 4:36 pm By:
Genetics News: Registration open for idiopathic pulmonary fibrosis healthcare summit: The Pulmonary Fibrosis Fou... http://bit.ly/dOhzQN
Sildenafil benefit small in patients with idiopathic pulmonary fibrosis
physorg.com — “Sildenafil failed to significantly increase exercise capacity, but did improve arterial oxygenation, shortness of breath and quality of life in patients with advanced idiopathic pulmonary fibrosis (IPF), in the first randomized trial of the medication for IPF. The study is published in the August 12, ...” View full resource at physorg.com
Most Recently Shared on September 22, 2010 at 1:19 pm By:
PhysOrg Health News Health News
Sildenafil benefit small in patients with idiopathic pulmonary fibrosis http://tw.physorg.com/204365935
ATS Issues Joint Statement On The Treatment Of Idiopathic Pulmonary Fibrosis
medicalnewstoday.com — “The American Thoracic Society has released new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF). The statement replaces ATS guidelines published” View full resource at medicalnewstoday.com
Most Recently Shared on March 18, 2011 at 9:05 am By:
ATS Issues Joint Statement On The Treatment Of Idiopathic Pulmonary Fibrosis http://mnt.to/3Sr6 #asthma
ATS Issues Joint Statement On The Treatment Of Idiopathic Pulmonary Fibrosis
medicalnewstoday.com — “The American Thoracic Society has released new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF). The statement replaces ATS guidelines published” View full resource at medicalnewstoday.com
Most Recently Shared on March 19, 2011 at 8:05 am By:
ATS Issues Joint Statement On The Treatment Of Idiopathic Pulmonary Fibrosis http://mnt.to/3Svk #asthma
Idiopathic Pulmonary Fibrosis Not Worsened By Viral Infections | ThirdAge
thirdage.com — “Idiopathic pulmonary fibrosis, a progressive and fatal form of lung disease, will not get worse as a result of exposure to a viral infection, according to new research.” View full resource at thirdage.com
Most Recently Shared on February 26, 2011 at 8:24 pm By:
Idiopathic Pulmonary Fibrosis Not Worsened By Viral Infections http://bit.ly/hiFayy
Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis
erj.ersjournals.com — “Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis” View full resource at erj.ersjournals.com
Most Recently Shared on November 17, 2011 at 6:48 pm By:
Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis. http://t.co/1og5CqVQ
Phase 3 Studies of Pirfenidone for Idiopathic Pulmonary Fibrosis - ONA
oncologynurseadvisor.com — “InterMune announced positive data from its CAPACITY Program studying pirfenidone for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 16, 2011 at 3:47 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Studies of Pirfenidone for Idiopathic Pulmonary Fibrosis http://goo.gl/fb/vWdYN
Researchers Profile Gene Activity in Acutely Ill Idiopathic Pulmonary Fibrosis Patients
newswise.com — “New research may help doctors pinpoint when patients with idiopathic pulmonary fibrosis (IPF) are becoming dangerously ill. The findings may also point the way to interventions that could sustain the lives of IPF patients until life-saving transplants could be performed.” View full resource at newswise.com
Most Recently Shared on July 7, 2009 at 4:56 pm By:
Researchers Profile Gene Activity in Acutely Ill Idiopathic Pulmonary Fibrosis Patients http://bit.ly/18JRxm
Pirfenidone reduces rate of lung decline in idiopathic pulmonary fibrosis
medicalxpress.com — “The CAPACITY study, published Online First and in an upcoming Lancet, shows that pirfenidone reduces the rate of decline of lung function in patients with idiopathic pulmonary fibrosis—a condition of unknown cause affecting hundreds of thousands of patients worldwide that leads to progressive lung ...” View full resource at medicalxpress.com
Most Recently Shared on May 13, 2011 at 10:30 pm By:
PhysOrg Health News Health News
Pirfenidone reduces rate of lung decline in idiopathic pulmonary fibrosis http://tw.medicalxpress.com/224506814
Phase 3 Studies of Pirfenidone for Idiopathic Pulmonary Fibrosis - MPR
empr.com — “InterMune announced positive data from its CAPACITY Program studying pirfenidone for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).” View full resource at empr.com
Most Recently Shared on May 16, 2011 at 3:32 pm By:
MPR News: Phase 3 Studies of Pirfenidone for Idiopathic Pulmonary Fibrosis: InterMune announced positive data fr... http://bit.ly/jgTAOZ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
-
Thom Canalichio
Bringing you the Latest Newswise Medical content.
Advertisement
